pubmed.ncbi.nlm.nih.gov

Therapeutic and prognostic role of vitamin D for COVID-19 infection: A systematic review and meta-analysis of 43 observational studies - PubMed

Meta-Analysis

Therapeutic and prognostic role of vitamin D for COVID-19 infection: A systematic review and meta-analysis of 43 observational studies

Fausto Petrelli et al. J Steroid Biochem Mol Biol. 2021 Jul.

Abstract

Vitamin D modulates the systemic inflammatory response through interaction with immune system. As such, it has a possible protective role against the risk of respiratory tract infections and other diseases. It may be useful in particular, during COVID-19 pandemic. PubMed, the Cochrane Library, and EMBASE were searched from inception until January 31, 2021, for observational or clinical studies reporting the prognosis (and therapeutic effect) of COVID-19 infection in patients with deficient vitamin D levels. The infection rate, severity, and death from COVID-19 infection were pooled to provide an odds ratio with a 95 % confidence interval (OR 95 % CI). An OR > 1 was associated with the worst outcome in deficient compared with nondeficient patients. We assessed the association between vitamin D and risk, severity, and mortality for COVID-19 infection, through a review of 43 observational studies. Among subjects with deficient vitamin D values, risk of COVID-19 infection was higher compared to those with replete values (OR = 1.26; 95 % CI, 1.19-1.34; P < .01). Vitamin D deficiency was also associated with worse severity and higher mortality than in nondeficient patients (OR = 2.6; 95 % CI, 1.84-3.67; P < .01 and OR = 1.22; 95 % CI, 1.04-1.43; P < .01, respectively). Reduced vitamin D values resulted in a higher infection risk, mortality and severity COVID-19 infection. Supplementation may be considered as preventive and therapeutic measure.

Keywords: COVID-19; Infection; Meta-analysis; Mortality; Vitamin D3.

Copyright © 2021 Elsevier Ltd. All rights reserved.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1

risk of covid-19 severity in patients with low vitamin D levels.

Similar articles

Cited by

References

    1. Heath A.K., Kim I.Y., Hodge A.M., English D.R., Muller D.C. Vitamin D status and mortality: a systematic review of observational studies. Int. J. Environ. Res. Public Health. 2019;16(3):383. doi: 10.3390/ijerph16030383. - DOI - PMC - PubMed
    1. Zhang Y., Fang F., Tang J., Jia L., Feng Y., Xu P., Faramand A. Association between vitamin D supplementation and mortality: systematic review and meta-analysis. BMJ. 2019;366 doi: 10.1136/bmj.l4673. Erratum in: BMJ. 2020;370:m2329. - DOI - PMC - PubMed
    1. Kempker J.A., Martin G.S. Vitamin D and sepsis: from associations to causal connections. Inflamm. Allergy Drug Targets. 2013;12:000. - PubMed
    1. Zdrenghea M.T., Makrinioti H., Bagacean C., et al. Vitamin D modulation of innate immune responses to respiratory viral infections. Rev. Med. Virol. 2017;27:e1909. - PubMed
    1. Arboleda J., Urcuqui-Inchima S. Vitamin D supplementation: a potential approach for COVID-19 therapeutics? Front. Immunol. 2020:11. - PMC - PubMed

Publication types

MeSH terms

Substances